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Bringing in the Green of damage from global wa rming. Two main threats-coral bleaching due to 
rising water temperature and the acidi-
fication of surface waters due to rising 
C0 2-have the potential to devastate an 
already fragile ecosystem. 
Pharma stands to win hearts, minds, and tax 
credits by launching an eco bandwagon 
Green mind-set can lead to 
a black bottom line. Becoming 
nviron menta lly friendly ca n 
help boost brand image and ROi-
and pharma can get there with a few 
easy steps. 
First, with about 90,000 sales rep-
resentatives on the road, the industry 
could lead a revolution in transporta-
tion if it bought hybrid cars. By replac-
ing the current fleet, the benefits would 
be substantial. Each hybrid is cheaper to 
maintain, more fuel-efficient, and leaves 
a far smaller greenhouse-gas footprint 
on the environment. Imagine extrapolat-
ing these benefits to thousands of ca rs: 
That's an environmentally friendly sig-
nature that shows leadership in the one-
armosphere world we live in. 
One promising indication is that at 
least two pharmaceutical companies are 
already providing incentives for their 
sales consultants to order hybrids once 
the leases on their current cars run out. 
Thanks to the Energy Policy Act of 
2005, pharma could even reap a tax 
credit for buying hybrid cars in bulk. 
Under that law, the government has 
begun awarding groundbrea king tax 
incentives to consumers and businesses 
that buy or lease new hybrid cars. The 
federal income tax credit ranges from 
$250 to $3,400, depending on the fuel 
economy and the weight of the vehicle. 
Additionally, hybrid manu fac turers 
might give pharmaceutica l companies 
a discount for such bulk purchases. 
Porcher L TmykM, 
Ill is an associate 
professor at the 
University of Rich-
mond. He can be 
reached at ptaylor@ 
richmond.edu 
Lastly, eco-conscious doctors and con-
sumers could be more inclined to buy 
from companies that lead the charge on 
buying hybrids. 
Big Pharma needs to create a CEO 
Roundtable on the Environment, mod-
eled after the CEO Roundtable on Can-
The second ecosystem the Roundtable 
must address is the Amazon rain forest. 
Seventy percent of plants found to have 
anticancer properties are un ique to the 
rain forest. Loss of this habitat is of seri-
ous concern for the industry. The world's 
ra in forests are already suffering the im-
An enviro-sensitive Big Pharma CEO might 
decide to launch a consortium, akin to 
the Roundtable on Cancer, to establish 
best practices to improve the environment 
ccr, an association of high-powered 
CEOs (mostly from Big Pharma) that 
seeks to forge best practices fo r anti-
cancer policies. An enviro-sensirive Big 
Pharma CEO might decide to launch 
such a consortium to establish best 
industry practices to improve the envi-
ronment. 
A top priority of this Roundtable 
must be the preservation of major eco-
systems affected by global warming. 
Loss of habitat and species diversity 
could have a direct financial impact on 
pharmaceutical R&D and global health. 
The great coral reefs are among the 
world 's most biologically diverse ecosys-
tems; they and associated organisms are 
a significant source of generic materia ls 
beneficial to pharma. These coral reefs, 
already under mounting pressure from 
human impact, are showing clear signs 
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pact of deforestation and habitat frag-
memation, and up to 50,000 species a 
year may be lost forever. Recent droughts 
and fires that reduced pa rts of the rain 
forest to dry savannah have highlighted 
concerns over global warming. Such dev-
astation serves as a clea r warning that 
the more frequent droughts predicted by 
many climate models could lead to in-
creased deforestation, species extinction, 
and accelerating climate change. 
A commitment by Big Pharma to 
the reduction o f global CO, would be 
a commitment toward the preservation 
of these fragile ecosystems. At the sa me 
time, an enhanced effort to preserve the 
genetic potential of some of the most 
vulnerable systems through research, 
documentat ion, and archiving will cre-
ate a va luable resource for the future, 
when the diversity we take for granted 
rnday may be a distant memory. 
There are clear and compelling fi-
nancial, corporate-citizenship, and con-
sumer-management arguments for the 
industry to aggressively become eco-
friend ly. T he first pharma company that 
adopts these Green practices and mar-
kets itself in this way may have a major 
competitive advantage within reach. • 
